Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teresa Lambe

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Molecular Medicine (Cambridge, Mass.)|June 28, 2012
Novel viral vectored vaccines for the prevention of influenzaTeresa Lambe
Vaccines|September 8, 2015
Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesLynda Coughlan, Teresa Lambe
Vaccines|May 26, 2018
Clinical Advances in Viral-Vectored Influenza VaccinesSarah Sebastian, Teresa Lambe
The Lancet. Infectious Diseases|April 22, 2021
Recombinant protein vaccines against SARS-CoV-2Sarah C Gilbert, Teresa Lambe
Immunology Letters|April 27, 2019
Vaccine platforms for the prevention of Lassa feverJyothi Purushotham, Teresa Lambe, Sarah C Gilbert
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 12, 2017
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Teresa Lambe, Georgina Bowyer, Katie J Ewer
Human Vaccines & Immunotherapeutics|February 14, 2023
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zosterMarta Ulaszewska, Sarah Merelie, Sarah Sebastian, et al.
Cell Biology International|April 25, 2006
Differential expression of connexin 43 in mouse mammary cellsTeresa Lambe, Darren Finlay, Madeline Murphy, et al.
Vaccines|July 2, 2021
What Constitutes Protective Immunity Following Yellow Fever Vaccination?Jolynne Mokaya, Derick Kimathi, Teresa Lambe, et al.
Current Opinion in Immunology|June 1, 2022
Viral vector vaccinesNaina McCann, Daniel O'Connor, Teresa Lambe, et al.
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Molecular Medicine (Cambridge, Mass.)|June 28, 2012
Novel viral vectored vaccines for the prevention of influenzaTeresa Lambe
Vaccines|September 8, 2015
Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and ChallengesLynda Coughlan, Teresa Lambe
Vaccines|May 26, 2018
Clinical Advances in Viral-Vectored Influenza VaccinesSarah Sebastian, Teresa Lambe
The Lancet. Infectious Diseases|April 22, 2021
Recombinant protein vaccines against SARS-CoV-2Sarah C Gilbert, Teresa Lambe
Immunology Letters|April 27, 2019
Vaccine platforms for the prevention of Lassa feverJyothi Purushotham, Teresa Lambe, Sarah C Gilbert
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|April 12, 2017
A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?Teresa Lambe, Georgina Bowyer, Katie J Ewer
Human Vaccines & Immunotherapeutics|February 14, 2023
Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zosterMarta Ulaszewska, Sarah Merelie, Sarah Sebastian, et al.
Cell Biology International|April 25, 2006
Differential expression of connexin 43 in mouse mammary cellsTeresa Lambe, Darren Finlay, Madeline Murphy, et al.
Vaccines|July 2, 2021
What Constitutes Protective Immunity Following Yellow Fever Vaccination?Jolynne Mokaya, Derick Kimathi, Teresa Lambe, et al.
Current Opinion in Immunology|June 1, 2022
Viral vector vaccinesNaina McCann, Daniel O'Connor, Teresa Lambe, et al.
Pageof 19